C

Checkmate Pharmaceuticals

15 employees

Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical Device
Therapeutics
Pharmaceutical

Date founded

2015

Funding rounds raised

Total raised

$85M

from 17 investors over 17 rounds

C

Checkmate Pharmaceuticals raised $85M on June 10, 2020

Investors: Omega Funds, Sectoral Asset Management, Sofinnova Ventures, Russia technology fund, Decheng Capital, Longitude Capital, Medicxi, venBio Partners, Novo Holdings and F-Prime Capital Partners

C

Checkmate Pharmaceuticals raised $22M on December 12, 2018

Investors: venBio Partners, Decheng Capital and F-Prime Capital Partners

C

Checkmate Pharmaceuticals raised $27M on June 15, 2017

Investors: venBio Partners, Sofinnova Ventures, Russia technology fund and F-Prime Capital Partners

C

Checkmate Pharmaceuticals raised $20M on August 12, 2015

Investors: venBio Partners and Sofinnova Ventures, Russia technology fund

FAQ